Froimson Mark
- SEC CIK
- 0001709050
In the past year, 1 open-market sale filing worth $10.9K and no purchases.
Current role at each company
- PCRX Pacira BioSciences, Inc.Directoras of Jun 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $10.9K
- 1 filing
- Net
- −$10.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Froimson Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 (view filing) | Mar 17 | 2 days | Froimson MarkDirector | SSale | −500 | $21.81 | −$10.9K | −2.4%20.1K after | |
| Aug 12, 2024 (view filing) | Aug 12 | Same day | Froimson MarkDirector | PPurchase | +1.40K | $11.58 | +$16.2K | +10.7%14.5K after | |
| May 11, 2022 (view filing) | May 9 | 2 days | Froimson MarkDirector | SSale | −1.00K | $59.37 | −$59.4K | −16.9%4.91K after |